盐酸氧烯洛尔
|
|
|
- CAS号:
- 6452-73-9
- 英文名:
- OXPRENOLOL HYDROCHLORIDE
- 英文别名:
- Laracor;Astawal;Katehat;Snering;Paritane;Trasacor;Trasicor;ba-39089;Rixiprol;Ranidrox
- 中文名:
- 盐酸氧烯洛尔
- 中文别名:
- 盐酸心得平;盐酸奥曲洛尔;盐酸氧烯洛尔;盐酸氧烯咯尔;氧烯洛尔盐酸盐;氧萘洛尔盐酸盐;盐酸氧化醇溶胶;盐酸氧烯洛尔对照品;化合物 T19793;盐酸氧烯咯尔 标准品
- CBNumber:
- CB3332849
- 分子式:
- C15H24ClNO3
- 分子量:
- 301.81
- MOL File:
- 6452-73-9.mol
|
|
|
盐酸氧烯洛尔性质、用途与生产工艺
Oxprenolol hydrochloride (Ba 39089) 是一种口服有效的 β-肾上腺素受体 (β-AR) 拮抗剂，Ki 为 7.10 nM。
Ki: 7.10 nM (β-adrenergic receptor)
Oxprenolol (200 mg/kg/day; administered orally; for 3 weeks) produces effective beta-blockade.
|
Animal Model:
|
Male rats (230 to 300 g body wt) of the Wistar strain
|
|
Dosage:
|
200 mg/kg
|
|
Administration:
|
Administered orally; daily for 3 weeks
|
|
Result:
|
This dosage produced effective beta-blockade.
|
类别
有毒物品
毒性分级
中毒
急性毒性
口服-大鼠LD50: 900 毫克/公斤
可燃性危险特性
可燃;燃烧产生有毒氮氧化物和氯化氢烟雾
储运特性
库房通风低温干燥; 与食品原料分开存放
灭火剂
干粉、泡沫、砂土、二氧化碳, 雾状水
盐酸氧烯洛尔
上下游产品信息
上游原料
下游产品
| 更新日期 | 产品编号 | 产品名称 | CAS编号 | 包装 | 价格 |
|---|
| 2024/01/16 | HY-B1486 | Oxprenolol hydrochloride | | 5 mg | 600元 |
| 2024/01/16 | HY-B1486 | 盐酸氧烯洛尔
Oxprenolol hydrochloride | 6452-73-9 | 10mM * 1mLin DMSO | 660元 |
盐酸氧烯洛尔
生产厂家
全球有 74家供应商
盐酸氧烯洛尔国内生产厂家
6452-73-9, 盐酸氧烯洛尔 相关搜索:
- Pharmaceuticals
- Intermediates & Fine Chemicals
- Aromatics
- Amines
- 药靶配体
- 杂质对照品
- 1-(2-(烯丙氧基)苯氧基)-3-(异丙基氨基)丙-2-醇 盐酸盐
- 盐酸氧化醇溶胶
- 盐酸氧烯洛尔对照品
- 氧萘洛尔盐酸盐
- 化合物 T19793
- 盐酸奥曲洛尔
- 氧烯洛尔盐酸盐 EP标准品
- 盐酸氧烯咯尔 标准品
- 盐酸心得平 USP标准品
- 盐酸氧烯洛尔
- 盐酸心得平
- 氧烯洛尔盐酸盐
- 盐酸氧烯咯尔
- 6452-73-9
- Adrenergic Receptor,high,Oxprenolol hydrochloride,disease angina,Ba-39089,heart,Inhibitor,Ba39089,inhibit,heartbeats,Oxprenolol,Ba 39089,Beta Receptor,pressure,hypertension,arrhythmia,blood
- Oxprenolol hydrochloride salt
- 4-ethylsulfonyl-N,N-dimethyl-4,4-diphenyl-2-butanamine hydrochloride
- 1-(2-(Allyloxy)phenoxy)-3-(isopropylamino)propan-2-ol hydrochloride
- OxprenololHCl
- Oxprenolol hydrochloride CRS
- OXPRENOLOL HYDROCHLORIDE USP/EP/BP
- Oxprenolol Hydrochloride (1483505)
- Evinrozit
- Ranidrox
- Rixiprol
- 2-Propanol, 1-[o-(allyloxy)phenoxy]-3-(isopropylamino)-, hydrochloride (7CI, 8CI)
- 2-Propanol, 1-[(1-methylethyl)amino]-3-[2-(2-propenyloxy)phenoxy]-, hydrochloride (9CI)
- 1-Isopropylamino-3-(o-allyloxyphenoxy)-2-propanol hydrochloride
- 1-Isopropyl-amino-2-hydroxy-3-(O-allyloxyphenoxy)propane hydrochloride
- 1-(o-Allyloxyphenoxy)-3-isopropylamino-2-propranol-hydrochloride
- 1-(o-Allyloxyphenoxy)-3-isopropylamino-2-propanol hydrochloride
- 1-(2-Allyloxyphenoxy)-2-hydroxy-3-isopropylaminopropane hydrochloride
- 1-(2'-Allyloxyphenoxy)-2-hydroxy-3-isopropylaminopropane hydrochloride
- (+-)-1-[o-(Allyloxy)phenoxy]-3-isopropylamino-2-propanol hydrochloride
- 2-Propanol, 1-(1-methylethyl)amino-3-2-(2-propenyloxy)phenoxy-, hydrochloride
- 1-[2-ALLYLOXYPHENOXY]-3-[ISOPROPYLAMINO]-2-PROPANOLHCl
- ciba39089ba
- c-39089-ba
- ba-39089
- 2-(o-allyloxyphenoxy)-2-hydroxy-n-isopropyl-1-propylaminehydrochloride
- 1-(o-allyloxyphenoxy)-3-isopropylaminopropan-2-olhydrochloride
- (RS)-1-(2-Allyloxyphenoxy)- 3-isopropylamino-2-propanol
- Oxprenolol Hydrochloride (200 mg)
- 1-[(1-Methylethyl)amino]-3-[2-(2-propenyloxy)phenoxy]-2-propanolhydrochloride
- Oxprenolol hydrochloride (en)
- 2-(o-allyloxyp
- Snering
- Okuspurecol
- Katehat
- Astawal
- Trasicor 80
- Trasicor